Product News
- Product News2023/05/11
- Oral ingestion of senolytics restores α-Klotho in humans and mice
Any IBL product introduced in this IBL news is applicable for research use only and it cannot be used for diagnosis or medical purpose.
A research group led by Dr. James L. Kirkland, Department of Internal Medicine, Division of General Medicine, Mayo Clinic, conducted 1) experiments using various primary human cells co-cultured with culture supernatants of senescent and non-senescent cells.
They conducted 2) an experiment in which senolytics was administered to aged mice, obese mice, and mice transplanted with senescent cells.
They also conducted 3) a study in which a combination of senolytics and drug was administered to patients with idiopathic pulmonary fibrosis.
In these, they assessed α-Klotho expression in cells and/or urinary α-Klotho in mice and humans.
As a result, 1) α-Klotho expression was decreased in various non-senescent cells exposed to secretome from senescent cells, and 2) in young mice transplanted with senescent cells, α-Klotho expression was decreased in the brain and in the urine.
They found that in aged mice, diet-induced obese mice, and mice transplanted with senescent cells, selective genetic and pharmacological depletion of senescent cells increased α-Klotho levels in the urine and in the kidney and brain in these mice.
And they reported 3) that administration of a combination of senolytics and drug to human patients with idiopathic pulmonary fibrosis restored urinary α-Klotho levels.
(Article)
Zhu Y et al. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans. EBioMedicine. 2022 Mar;77:103912.
(Background)
α-Klotho has been studied as an anti-aging protein that may help mitigate the deleterious changes and diseases associated with aging.
Indeed, decreased α-Klotho has been reported as a hallmark of various diseases and aging.
Previous nonclinical studies have suggested that boosting α-Klotho expression may have therapeutic potentials, but no practical means of increasing α-Klotho levels were known.
In this report, it is noteworthy that orally ingestible senolytics improved aging and restored α-Klotho levels in mice and humans.
In this paper, our ELISA kits below are used to measure α-Klotho in mouse and human urine.
#27601 Mouse soluble α-Klotho Assay Kit - IBL
#27998 Human soluble α-Klotho Assay Kit - IBL
We hope that we can support your research.
Please feel free to contact us.
Sales Department
Antibody related Business Division
Immuno-Biological Laboratories Co., Ltd.
Email: do-ibl@ibl-japan.co.jp
IBL-Japan (Specific Antibody Development) 30sec video
IBL-Japan (Specific Antibody Development) 2min video
LipoSEARCH® - Lipoprotein Analyzing Systems (Patented GP-HPLC Systems) 30sec video
A research group led by Dr. James L. Kirkland, Department of Internal Medicine, Division of General Medicine, Mayo Clinic, conducted 1) experiments using various primary human cells co-cultured with culture supernatants of senescent and non-senescent cells.
They conducted 2) an experiment in which senolytics was administered to aged mice, obese mice, and mice transplanted with senescent cells.
They also conducted 3) a study in which a combination of senolytics and drug was administered to patients with idiopathic pulmonary fibrosis.
In these, they assessed α-Klotho expression in cells and/or urinary α-Klotho in mice and humans.
As a result, 1) α-Klotho expression was decreased in various non-senescent cells exposed to secretome from senescent cells, and 2) in young mice transplanted with senescent cells, α-Klotho expression was decreased in the brain and in the urine.
They found that in aged mice, diet-induced obese mice, and mice transplanted with senescent cells, selective genetic and pharmacological depletion of senescent cells increased α-Klotho levels in the urine and in the kidney and brain in these mice.
And they reported 3) that administration of a combination of senolytics and drug to human patients with idiopathic pulmonary fibrosis restored urinary α-Klotho levels.
(Article)
Zhu Y et al. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans. EBioMedicine. 2022 Mar;77:103912.
(Background)
α-Klotho has been studied as an anti-aging protein that may help mitigate the deleterious changes and diseases associated with aging.
Indeed, decreased α-Klotho has been reported as a hallmark of various diseases and aging.
Previous nonclinical studies have suggested that boosting α-Klotho expression may have therapeutic potentials, but no practical means of increasing α-Klotho levels were known.
In this report, it is noteworthy that orally ingestible senolytics improved aging and restored α-Klotho levels in mice and humans.
In this paper, our ELISA kits below are used to measure α-Klotho in mouse and human urine.
#27601 Mouse soluble α-Klotho Assay Kit - IBL
#27998 Human soluble α-Klotho Assay Kit - IBL
We hope that we can support your research.
Please feel free to contact us.
Sales Department
Antibody related Business Division
Immuno-Biological Laboratories Co., Ltd.
Email: do-ibl@ibl-japan.co.jp
IBL-Japan (Specific Antibody Development) 30sec video
IBL-Japan (Specific Antibody Development) 2min video
LipoSEARCH® - Lipoprotein Analyzing Systems (Patented GP-HPLC Systems) 30sec video